Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Colorado Springs, CO, July 27, 2026 (GLOBE NEWSWIRE) -- The use of generative artificial intelligence (AI) is quickly becoming nearly universal, and it has profoundly changed how...
-
Danone subsidiary The Akkermansia Company announced recent patent and legal developments supporting global commercialization of Akkermansia MucT®.
-
DALLAS, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence, strategy, and law firm, today released its latest PatentVest Pulse, an in-depth analysis of...
-
AI Era Corp. Reports Fiscal Third Quarter and Nine-Month Results
-
PharmAla signs definitive agreement with Jupiter Neurosciences to out-license their patented ALA-002 molecule, securing up-front and development payments.
-
Colorado Springs, CO, July 20, 2026 (GLOBE NEWSWIRE) -- Small technology companies often grow by using consultants, engineering firms, software developers, university researchers, prototype...
-
Route 92 Medical celebrates the 200th patent for its neurovascular intervention portfolio.
-
Dublin, July 16, 2026 (GLOBE NEWSWIRE) -- The "Intellectual Property (IP) Economy Market Research Report 2026-2031" has been added to ResearchAndMarkets.com's offering.The global intellectual...
-
Adeia to Release Second Quarter 2026 Financial Results on August 3, 2026
-
PharmAla announces the completion of manufacture of ALA-002 drug substance, as well as a full operational update on the LaNeo Gen 2 patented drug family.